Solution
FORTACIN CUTANEOUS SPRAY, SOLUTION 150MG/ML+50MG/ML
Summary
FORTACIN CUTANEOUS SPRAY, SOLUTION 150MG/ML+50MG/ML — Solution containing lignocaine, prilocaine. Hong Kong Registration No. HK-65931. Certificate Holder: ORIENT EUROPHARMA CO. LTD. Date of Registration: 19 Oct, 2018.
Product NameFORTACIN CUTANEOUS SPRAY, SOLUTION 150MG/ML+50MG/ML
Registration No.HK-65931
Certificate HolderORIENT EUROPHARMA CO. LTD
Holder AddressFLAT 605-6 6/F PROSPERITY CENTRE, 25 CHONG YIP STREET, KWUN TONG, KOWLOON
Ingredientslignocaine, prilocaine
Dosage FormSolution
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration19 Oct, 2018
ATC codesC01BB01, C05AD01, D04AB01, N01BB02, N01BB04, R02AD02, S01HA07, S02DA01
ATC Classification
ATC level 1
C Cardiovascular System / D Dermatologicals / N Nervous System / R Respiratory System / S Sensory Organs
All ATC groupsC01, C05, D04, N01, R02, S01, S02
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。